/C O R R E C T I O N — Veloxis Pharmaceuticals A/S/

In the news release, Veloxis Pharmaceuticals to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress ...